Co Galway-based medical devices firm Creganna has announced the acquisition of US firm Avalon Medical Services, which trades as Tactx Medical.
In a statement, it said the company, to be known as Creganna - Tactx Medical, will be “positioned as a world leader in the provision of technologies and services for minimally invasive delivery and access devices”.
It will offer a range of technologies and services for minimally invasive delivery and access devices, with a particular emphasis on high end therapeutic catheters.
Creganna chief executive Helen Ryan said the move was a key step in the company’s vision to build a leading global medical technology company
“Our customers, medical device companies, are increasingly looking to strategic partners to fulfil more of their supply chain requirements,” she said. “With our global locations, combined technologies and range of service Creganna - Tactx Medical is strategically positioned to meet these evolving needs.”
She said the new company, with bases in Ireland, California, Minnesota, Massachusetts and Singapore, will have a presence in many of the key medical device markets.
Creganna - Tactx Medical will have more than 800 staff worldwide and a combined revenue of $110 million in 2009. Terms of the transaction were not disclosed.
Creganna employs over 500 staff at its manufacturing plant in the Parkmore West business campus outside Galway. It has a second facility in Marlbrough, Massachusetts. Founded in 1979 as an engineering company, it decided to concentrate exclusively on medical devices in 1999.
Creganna manufactures components and complete medical devices, but sells to other medical device firms and not directly to customers.
It concentrates on medical devices for minimally invasive procedures and this includes specialist needles for use in medical procedures such as biopsies and catheter or delivery shafts. These are designed to follow the natural entry points to the body such as the gastrointestinal system.